CNC Logo

Centene Corporation (CNC) 

NYSE$62.82+1.47 (2.40%)
Market Cap
$30.43B
Sector
Healthcare
Industry
Medical—Healthcare Plans
Rank in Sector
86 of 893
Rank in Industry
2 of 10

CNC Insider Trading Activity

CNC Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$3,269,546
7
78
Sells
$688,342
2
22

Related Transactions

Greco Thomasdirector
1
$1.02M
0
$0
$1.02M
Asher Andrew LynnChief Financial Officer
1
$1M
0
$0
$1M
COUGHLIN CHRISTOPHER Jdirector
1
$594,400
1
$67,382
$527,018
Samuels Theodore R. IIdirector
1
$294,300
0
$0
$294,300
LONDON SARAHChief Executive Officer
1
$250,314
0
$0
$250,314
Dallas H Jamesdirector
1
$99,904
0
$0
$99,904
BLUME JESSICA L.director
1
$14,870
0
$0
$14,870
FASOLA KENNETH JPresident
0
$0
1
$620,960
$-620,960

About Centene Corporation

Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and â€¦

Insider Activity of Centene Corporation

Over the last 12 months, insiders at Centene Corporation have bought $3.27M and sold $688,342 worth of Centene Corporation stock.

On average, over the past 5 years, insiders at Centene Corporation have bought $2.8M and sold $32.37M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Greco Thomas (director) — $1.02M. Asher Andrew Lynn (Chief Financial Officer) — $1M. COUGHLIN CHRISTOPHER J (director) — $594,400.

The last purchase of 17,000 shares for transaction amount of $1.02M was made by Greco Thomas (director) on 2024‑12‑18.

List of Insider Buy and Sell Transactions, Centene Corporation

2024-12-18PurchaseGreco Thomasdirector
17,000
0.0034%
$59.75
$1.02M
+1.28%
2024-12-16PurchaseCOUGHLIN CHRISTOPHER Jdirector
10,000
0.002%
$59.44
$594,400
+1.79%
2024-12-16PurchaseDallas H Jamesdirector
1,693
0.0003%
$59.01
$99,904
+1.79%
2024-12-16PurchaseBLUME JESSICA L.director
250
<0.0001%
$59.48
$14,870
+1.79%
2024-12-13PurchaseSamuels Theodore R. IIdirector
5,000
0.001%
$58.86
$294,300
+1.20%
2024-11-13PurchaseAsher Andrew LynnChief Financial Officer
17,200
0.0034%
$58.14
$1M
+2.88%
2024-11-08PurchaseLONDON SARAHChief Executive Officer
4,117
0.0008%
$60.80
$250,314
-0.77%
2024-05-14SaleCOUGHLIN CHRISTOPHER Jdirector
878
0.0002%
$76.75
$67,382
-15.87%
2024-05-13SaleFASOLA KENNETH JPresident
8,000
0.0015%
$77.62
$620,960
-16.11%
2024-02-13SaleRobinson Lori Jeandirector
10,000
0.0019%
$77.41
$774,100
-7.13%
2024-02-07SaleFASOLA KENNETH JPresident
12,000
0.0023%
$75.07
$900,818
-4.40%
2023-04-27SaleRobinson Lori Jeandirector
1,400
0.0002%
$66.59
$93,226
+3.45%
2023-03-17PurchaseLONDON SARAHChief Executive Officer
30,000
0.0055%
$62.60
$1.88M
+10.24%
2023-02-10PurchaseAsher Andrew LynnEVP, CFO
3,800
0.0007%
$71.97
$273,486
-5.84%
2023-02-09PurchaseAsher Andrew LynnEVP, CFO
3,000
0.0005%
$71.89
$215,670
-4.28%
2023-02-08PurchaseMURRAY JAMES EEVP, Chief Operating Officer
6,750
0.0012%
$73.30
$494,775
-6.06%
2023-02-08PurchaseSamuels Theodore R. IIdirector
7,000
0.0013%
$71.88
$503,160
-6.06%
2022-07-29SaleBAGLEY SHANNONEVP, Chief Admin. Officer
9,000
0.0016%
$92.21
$829,890
-20.16%
2022-07-28SaleRobinson Lori Jean
1,200
0.0002%
$92.77
$111,324
-19.55%
2022-07-08SaleGEPHARDT Richard A
4,480
0.0008%
$88.00
$394,240
-13.83%
Total: 363
*Gray background shows transactions not older than one year

Insider Historical Profitability

10.22%
LONDON SARAHChief Executive Officer
667229
0.1345%
$40.93M20
+10.24%
Asher Andrew LynnChief Financial Officer
486847
0.0981%
$29.87M30
<0.0001%
COUGHLIN CHRISTOPHER Jdirector
36358
0.0073%
$2.23M21
+0.95%
Samuels Theodore R. IIdirector
23000
0.0046%
$1.41M30
<0.0001%
Greco Thomasdirector
19309
0.0039%
$1.18M10
Dallas H Jamesdirector
1693
0.0003%
$103,865.5520
+0.95%
BLUME JESSICA L.director
250
0.0001%
$15,337.5020
+12.65%
NEIDORFF MICHAEL FChairman & CEO
6404073
1.291%
$392.89M143
<0.0001%
ROBERTS JOHN Rdirector
194465
0.0392%
$11.93M24
+15.73%
SCHEFFEL WILLIAM NExec VP, CFO & Treasurer
186987
0.0377%
$11.47M16
+33.45%
Thompson Tommy Gdirector
160896
0.0324%
$9.87M38
+21.41%
MURRAY JAMES EEVP, Chief Operating Officer
136220
0.0275%
$8.36M10
<0.0001%
AYALA ORLANDOdirector
74879
0.0151%
$4.59M19
+31.65%
DITMORE ROBERT Kdirector
56330
0.0114%
$3.46M326
+4.74%
BARTLETT STEVEdirector
29554
0.006%
$1.81M50
+16.18%
JOSEPH PAMELA Adirector
17398
0.0035%
$1.07M10
+5.94%
STEWARD DAVID Ldirector
9500
0.0019%
$582,825.0010
+16.99%
*Gray background shows insiders who have made transactions during last year

CNC Institutional Investors: Active Positions

Increased Positions421+39.24%57M+11.66%
Decreased Positions488-45.48%68M-13.86%
New Positions137New13MNew
Sold Out Positions128Sold Out9MSold Out
Total Postitions1,006-6.24%481M-2.2%

CNC Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$3.6M11.72%58.11M-2M-3.28%2024-12-31
Blackrock, Inc.$2.63M8.57%42.52M-3M-6.77%2024-12-31
Harris Associates L P$1.57M5.12%25.4M-914,057-3.47%2024-12-31
Norges Bank$1.57M5.11%25.36M+4M+19.54%2024-12-31
State Street Corp$1.41M4.59%22.77M-702,113-2.99%2024-12-31
Fmr Llc$1.33M4.32%21.43M-3M-12.79%2024-12-31
Capital World Investors$1.08M3.53%17.5M-5M-22.43%2024-12-31
Wellington Management Group Llp$949,680.003.09%15.33M-2M-11.5%2024-12-31
Geode Capital Management, Llc$772,332.002.51%12.47M-185,915-1.47%2024-12-31
Invesco Ltd.$653,699.002.13%10.56M+2M+21.73%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.